Bassel Rifai - Ambu AS Chief VP

AMBBY Stock  USD 13.60  0.18  1.31%   

Insider

Bassel Rifai is Chief VP of Ambu AS
Phone45 72 25 20 00
Webhttps://www.ambu.com

Ambu AS Management Efficiency

The company has return on total asset (ROA) of 0.0141 % which means that it generated a profit of $0.0141 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.0236 %, meaning that it generated $0.0236 on every $100 dollars invested by stockholders. Ambu AS's management efficiency ratios could be used to measure how well Ambu AS manages its routine affairs as well as how well it operates its assets and liabilities.
Ambu AS has accumulated 1.25 B in total debt with debt to equity ratio (D/E) of 0.36, which is about average as compared to similar companies. Ambu AS has a current ratio of 1.9, which is within standard range for the sector. Debt can assist Ambu AS until it has trouble settling it off, either with new capital or with free cash flow. So, Ambu AS's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Ambu AS sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Ambu to invest in growth at high rates of return. When we think about Ambu AS's use of debt, we should always consider it together with cash and equity.

Similar Executives

Showing other executives

INSIDER Age

Mike WangCarl Zeiss Meditec
N/A
Mike WangCarl Zeiss Meditec
N/A
Martin WiechmannCarl Zeiss Meditec
N/A
Laurie FergusonCarl Zeiss Meditec
N/A
Andrew ChangCarl Zeiss Meditec
N/A
Federico PozAmplifon SpA
45
Colleen HarrisRamsay Health Care
54
Giuseppe VirondaAmplifon SpA
N/A
Salvatore RiccoAmplifon SpA
N/A
Steven MDCarl Zeiss Meditec
N/A
Eri WatanabeNihon Kohden Corp
N/A
Natsumi KajiyamaNihon Kohden Corp
N/A
AC DScRamsay Health Care
70
Kelly HibbinsRamsay Health Care
N/A
Andrew JonesRamsay Health Care
49
Euan ThomsonCarl Zeiss Meditec
60
LLB BECONRamsay Health Care
N/A
Andrew WearneRamsay Health Care
N/A
Markus WeberCarl Zeiss Meditec
N/A
Kah HongRamsay Health Care
50
Doug MeagherRamsay Health Care
N/A
Ambu AS develops, produces, and sells medical devices to hospitals, clinics, and rescue services worldwide. Ambu AS was founded in 1937 and is headquartered in Ballerup, Denmark. Ambu AS is traded on OTC Exchange in the United States. Ambu AS [AMBBY] is a Pink Sheet which is traded between brokers over the counter.

Management Performance

Ambu AS Leadership Team

Elected by the shareholders, the Ambu AS's board of directors comprises two types of representatives: Ambu AS inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Ambu. The board's role is to monitor Ambu AS's management team and ensure that shareholders' interests are well served. Ambu AS's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Ambu AS's outside directors are responsible for providing unbiased perspectives on the board's policies.
Thomas Schmidt, Ex CFO
Henrik Ankjr, Ex Operations
Thomas Henriksen, Director, Employee Representative
Anders Williamsson, Managing Director
Steven Block, CEO USA
Nicolai Thomsen, Director Planning
Mikkel Wagner, Director Communications
Bassel Rifai, Chief VP
Mns Barsne, Ex Officer
Britt Jensen, Chief Officer

Ambu Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is Ambu AS a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Ambu Pink Sheet Analysis

When running Ambu AS's price analysis, check to measure Ambu AS's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ambu AS is operating at the current time. Most of Ambu AS's value examination focuses on studying past and present price action to predict the probability of Ambu AS's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ambu AS's price. Additionally, you may evaluate how the addition of Ambu AS to your portfolios can decrease your overall portfolio volatility.